Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy. According to our (Global Info Research) latest study, the global Preimplantation Genetic Testing market size was valued at USD 356.1 million in 2022 and is forecast to a readjusted size of USD 519.8 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions. This report is a detailed and comprehensive analysis for global Preimplantation Genetic Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided. Key Features: Global Preimplantation Genetic Testing market size and forecasts, in consumption value ($ Million), 2018-2029 Global Preimplantation Genetic Testing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029 Global Preimplantation Genetic Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029 Global Preimplantation Genetic Testing market shares of main players, in revenue ($ Million), 2018-2023 The Primary Objectives in This Report Are: To determine the size of the total market opportunity of global and key countries To assess the growth potential for Preimplantation Genetic Testing To forecast future growth in each product and end-use market To assess competitive factors affecting the marketplace This report profiles key players in the global Preimplantation Genetic Testing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Thermo Fisher, Agilent Technologies, Perkinelmer and Coopersurgical, etc. This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence. Market segmentation Preimplantation Genetic Testing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets. Market segment by Type Preimplantation Genetic Screening Preimplantation Genetic Diagnosis Market segment by Application Maternity Centers & Fertility Clinics Hospitals, Diagnostic Labs, and Service Providers Research Laboratories & Academic Institutes Market segment by players, this report covers Illumina Thermo Fisher Agilent Technologies Perkinelmer Coopersurgical Abbott Laboratories Natera Rubicon Genomics Oxford Gene Technology Yikon Genomics Scigene Beijing Genomics Institute Good Start Genetics Invicta Genetics Combimatrix Genea Limited Progenesis Market segment by regions, regional analysis covers North America (United States, Canada, and Mexico) Europe (Germany, France, UK, Russia, Italy, and Rest of Europe) Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific) South America (Brazil, Argentina and Rest of South America) Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa) The content of the study subjects, includes a total of 13 chapters: Chapter 1, to describe Preimplantation Genetic Testing product scope, market overview, market estimation caveats and base year. Chapter 2, to profile the top players of Preimplantation Genetic Testing, with revenue, gross margin and global market share of Preimplantation Genetic Testing from 2018 to 2023. Chapter 3, the Preimplantation Genetic Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast. Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029. Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Preimplantation Genetic Testing market forecast, by regions, type and application, with consumption value, from 2024 to 2029. Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War Chapter 12, the key raw materials and key suppliers, and industry chain of Preimplantation Genetic Testing. Chapter 13, to describe Preimplantation Genetic Testing research findings and conclusion.
1 Market Overview 1.1 Product Overview and Scope of Preimplantation Genetic Testing 1.2 Market Estimation Caveats and Base Year 1.3 Classification of Preimplantation Genetic Testing by Type 1.3.1 Overview: Global Preimplantation Genetic Testing Market Size by Type: 2018 Versus 2022 Versus 2029 1.3.2 Global Preimplantation Genetic Testing Consumption Value Market Share b
